bpc 157 safety adverse effects toxicity The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and BPC-157 as an Investigational Peptide
Description
500 mcg = 0.5 mg)
[20] Use of BPC-157 is discouraged by health authorities and it has been controlled as a prescription medicine in several jurisdictions such as New Zealand and Australia, despite not actually being available for prescription
Researchers should employ standard laboratory safety protocols including the use of gloves and eye protection when handling the product
USP Pharmaceutical Compounding-Sterile Preparations
